Pamicell Attracts Individual Investors' Attention... Stock Price Up 1.55%...
Recently, there has been a surge in search frequency for Pharmicell, a bio-pharmaceutical company known for developing the world's first stem cell therapy.
As of 12:31 PM on the 6th, Pharmicell's stock price is 19,600 KRW, up 1.55% from the previous day, with a trading volume of 2,691,546 shares, which is about 83.92% of the 5-day average trading volume. Foreign investors are tentatively estimated to have net purchased 65,000 shares today.
On October 5th, Pharmicell became a market issue with the headline "Soars on news of President Trump's Remdesivir administration."
Hot Picks Today
"Now Our Salaries Are 10 Million Won a Month" Record High... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Already Watching Closely..."Target Price Set at 970,000 Won" Only Upward Momentum Remains [Weekend Money]
- Prime Minister Kim Minseok: "Samsung Electronics Strike Could Cost Up to 1 Trillion Won per Day, 100 Trillion Won Total... Tomorrow's Talks Are the Last Chance" (Comprehensive)
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
- Is It Really Like an Illness? "I Can't Wait to Go Again"—Over 1 Million Visited in Q1, Now 'Busanbyeong' Takes Hold [K-Holic]
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
